tiprankstipranks
Advertisement
Advertisement

SRZN Stock Latest News

Surrozen Shareholders Support Board, Auditor and Pay Policies
Company AnnouncementsSurrozen Shareholders Support Board, Auditor and Pay Policies
16d ago
8K
SRZN
Surrozen price target raised to $44 from $36 at H.C. Wainwright
PremiumThe Fly
Surrozen price target raised to $44 from $36 at H.C. Wainwright
24d ago
SRZN
Surrozen Earns Buy Rating on Advancing Retinal Pipeline, Strong Cash Runway, and Large wAMD/DME Market Opportunity
PremiumRatings
Surrozen Earns Buy Rating on Advancing Retinal Pipeline, Strong Cash Runway, and Large wAMD/DME Market Opportunity
24d ago
SRZN
Surrozen reports Q1 EPS ($11.65) vs. ($7.43) last year
PremiumThe Fly
Surrozen reports Q1 EPS ($11.65) vs. ($7.43) last year
24d ago
SRZN
Surrozen management to meet with Cantor
PremiumThe Fly
Surrozen management to meet with Cantor
1M ago
SRZN
Surrozen: Buy Rating Reiterated as Analyst Highlights Wnt-Targeted Ophthalmology Strategy and Maintains $37 Price Target
PremiumRatingsSurrozen: Buy Rating Reiterated as Analyst Highlights Wnt-Targeted Ophthalmology Strategy and Maintains $37 Price Target
1M ago
SRZN
Surrozen initiated with a Buy at TD Cowen
Premium
The Fly
Surrozen initiated with a Buy at TD Cowen
1M ago
SRZN
Surrozen price target raised to $36 from $32 at H.C. Wainwright
Premium
The Fly
Surrozen price target raised to $36 from $32 at H.C. Wainwright
2M ago
SRZN
Surrozen files $200M mixed securities shelf
PremiumThe Fly
Surrozen files $200M mixed securities shelf
2M ago
SRZN
Surrozen, Inc. (SRZN) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Surrozen, Inc. (SRZN) Q4 Earnings Cheat Sheet
2M ago
SRZN
Surrozen initiated with an Overweight at Cantor Fitzgerald
PremiumThe Fly
Surrozen initiated with an Overweight at Cantor Fitzgerald
3M ago
SRZN
Surrozen announces routine board resignation with no disputes
PremiumCompany Announcements
Surrozen announces routine board resignation with no disputes
4M ago
8K
SRZN
Surrozen’s Innovative Wnt-Targeted Therapies Poised to Disrupt $15 Billion Anti-VEGF Market: A Compelling Buy Recommendation
PremiumRatingsSurrozen’s Innovative Wnt-Targeted Therapies Poised to Disrupt $15 Billion Anti-VEGF Market: A Compelling Buy Recommendation
7M ago
SRZN
Surrozen initiated with an Outperform at LifeSci Capital
Premium
The Fly
Surrozen initiated with an Outperform at LifeSci Capital
7M ago
SRZN
Surrozen, Inc. Reports Significant Q3 2025 Loss
Premium
Company Announcements
Surrozen, Inc. Reports Significant Q3 2025 Loss
7M ago
SRZN
Surrozen’s Innovative Wnt Pathway Advancements in Retinal Disease Treatment Earns Buy Rating
PremiumRatings
Surrozen’s Innovative Wnt Pathway Advancements in Retinal Disease Treatment Earns Buy Rating
7M ago
SRZN
Surrozen Appoints Andrew Maleki as New CFO
PremiumCompany Announcements
Surrozen Appoints Andrew Maleki as New CFO
7M ago
8K
SRZN
Surrozen names Andrew Maleki as CFO
PremiumThe Fly
Surrozen names Andrew Maleki as CFO
7M ago
SRZN
Surrozen’s Collaboration Agreement with TCGFB Terminated
PremiumCompany Announcements
Surrozen’s Collaboration Agreement with TCGFB Terminated
8M ago
8K
SRZN
Surrozen Signs $50M Sales Agreement with TD Securities
PremiumCompany AnnouncementsSurrozen Signs $50M Sales Agreement with TD Securities
9M ago
8K
SRZN
Surrozen’s Innovative Wnt Pathway Approach Garners Buy Rating Amid Promising Preclinical Data
Premium
Ratings
Surrozen’s Innovative Wnt Pathway Approach Garners Buy Rating Amid Promising Preclinical Data
10M ago
SRZN
Surrozen’s Q2 2025: Progress in Eye Disease Therapies
Premium
Company Announcements
Surrozen’s Q2 2025: Progress in Eye Disease Therapies
10M ago
SRZN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >